IP Diligence

IP risks often drive deal terms in life science company technology transactions.

Our deep technical expertise in securing and litigating IP assets allows our attorneys to provide strategic advice on complex life science deals where intellectual property is a critical consideration. With a patent prosecutor’s eye, we analyze IP assets and technologies underlying the transaction. With a litigator’s perspective, we quantify uncertainty and counsel our clients with creative strategies to mitigate risk.

As a result of our diligence, our clients can understand the IP risks in a given proposed deal and avoid making ill‑advised investments. We assess the likelihood that the target company will have to defend against patent litigation claims and the likelihood of prevailing. We also analyze entire patent portfolios to locate gaps in patent coverage and determine whether the patent portfolio acts as an effective barrier to entry into the target company’s market.